Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$6,729 Mln
Revenue (TTM)
$1,291 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
35.7
P/B Ratio
3.1
Industry P/E
51.19
EV/EBITDA
16
Div. Yield
0 %
Debt to Equity
0.5
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
86,156,334
CFO
$1,104.25 Mln
EBITDA
$1,281.24 Mln
Net Profit
$208.19 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
| -11.4 | 5.2 | -15.0 | -20.2 | 13.3 | 2.6 | 13.4 |
|
BSE Sensex*
| -12.0 | -9.7 | -12.2 | -1.2 | 8.7 | 8.4 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
| -4.5 | 44.3 | 7.6 | 39.3 | -36.5 | -5.9 | 24.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
81.1 | 6,728.7 | 1,290.7 | 191.8 | 23.7 | 9 | 35.7 | 3.1 |
| 166.8 | 6,208.3 | 950.8 | 140.9 | 16.5 | 26.5 | 44.5 | 11.4 | |
| 4.2 | 7,951.2 | 3.0 | -816.0 | -29,333.3 | -40.6 | -- | 3.7 | |
| 48.8 | 6,034.6 | 900.8 | 109.2 | 21.9 | 58.1 | 40 | 25.0 | |
| 23.4 | 6,918.6 | 731.4 | -38.8 | 1.5 | -2.6 | -- | 3.4 | |
| 25.2 | 6,448.5 | 2,521.0 | 508.4 | 28.7 | -39.9 | 13.8 | 29.8 | |
| 43.2 | 7,204.7 | 1,745.8 | 393.4 | 16.1 | 57.3 | 19.9 | 15.8 | |
| 12.3 | 11,493.6 | 1,016.9 | -297.0 | -16.1 | -4.4 | -- | 1.3 | |
| 12.2 | 6,080.1 | 1,610.6 | 282.3 | 3.8 | 15.1 | 27.1 | 3.2 | |
| 19.2 | 8,413.0 | 1,849.7 | -402.8 | -20.4 | -12.5 | -- | 2.6 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It provides health savings accounts; investment platform; and online-only automated investment advisory services through Advisor, a... Web-based tool. The company also offers flexible spending accounts for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah. Read more
President, CEO & Director
Mr. Jon Kessler
President, CEO & Director
Mr. Jon Kessler
Headquarters
Draper, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of HealthEquity Inc (HQY) is $81.13 (NASDAQ) as of 19-Mar-2026 16:00 EDT. HealthEquity Inc (HQY) has given a return of 13.27% in the last 3 years.
The P/E ratio of HealthEquity Inc (HQY) is 35.69 times as on 13-Mar-2026, a 30 discount to its peers’ median range of 51.19 times.
The P/B ratio of HealthEquity Inc (HQY) is 3.12 times as on 13-Mar-2026, a 46 discount to its peers’ median range of 5.82 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of HealthEquity Inc (HQY) are Rs 116.65 and Rs 72.76 as of 20-Mar-2026.
HealthEquity Inc (HQY) has a market capitalisation of $ 6,729 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in HealthEquity Inc (HQY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$1.56
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.